Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Establishing a framework towards monitoring HCV microelimination among men who have sex with men living with HIV in Germany: A modeling analysis

PLoS ONE(2022)10.1371/journal.pone.0267853Source: DataRank Database

Establishing a framework towards monitoring HCV microelimination among men who have sex with men living with HIV in Germany: A modeling analysis is a research paper published in PLoS ONE (2022). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (13 grants)Impact (FWCI 0.62)OA: goldTopics (106)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Patrick Ingiliz ORCID,Christoph Boesecke ORCID,Ivanka Krznaric ORCID,Knud Schewe,Thomas A. Lutz ORCID

Live enrichment

PubMed:35551326 PMC:PMC9098082 OpenAlex:https://openalex.org/W4280597338

National Institute on Drug Abuse

Grant: T32 DA023356

Fogarty International Center

Grant: D43TW009343

Gilead Sciences

Grant: IN-DE-987-4637

Gilead Sciences

Grant: IN-FR-980-6332

National Institute of Allergy and Infectious Diseases

Grant: R01 AI135992

National Institutes of Health, San Diego Center for AIDS Research

Grant: P30 AI036214

National Institute of Allergy and Infectious Diseases/ National Institute on Drug Abuse

Grant: R01AI147490

NCATS NIH HHS

Grant: UL1 TR001442

National Institutes of Health

Grant: 5R01AI135992-02

Automation and Evaluation of Real-Time Transmission Network-Based HIV Prevention Services in New York City

National Institutes of Health

Grant: 5D43TW009343-07

University of California Global Health Institute Program for Fellows and Scholars

National Institutes of Health

Grant: 2T32DA023356-06

Training Program in Substance Use, HIV and Related Infections

National Institutes of Health

Grant: 5P30AI036214-11

Center for AIDS Research

National Institutes of Health

Grant: 5R01AI147490-04

Optimizing HIV prevention portfolios targeting people who inject drugs using dynamic economic modeling

FWCI

0.62

Citation Percentile

0.6%

Citation Trend

2023

2024

goldLicense: cc-by

journalhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0267853&type=printable

publisherhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0267853&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pone.0267853

journalhttps://doi.org/10.1371/journal.pone.0267853

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35551326

Fields of Study

Hepatitis C virus researchHIV-related health complications and treatmentsDiabetes Management and Education0302 clinical medicine03 medical and health sciences

MeSH Terms

Sexual and Gender MinoritiesCOVID-19Antiviral AgentsGermanyHepatitis CHumansMaleProspective StudiesHIV InfectionsIncidenceHepacivirusHomosexuality, MaleHepatitis C, ChronicPandemics

Keywords

Men who have sex with menMedicineIncidence (geometry)Treatment as preventionHepatitis CPandemicTransmission (telecommunications)Hepatitis C virusDemographyViral loadHuman immunodeficiency virus (HIV)Environmental healthVirologyInternal medicineCoronavirus disease 2019 (COVID-19)DiseaseVirusSyphilisAntiretroviral therapyInfectious disease (medical specialty)MaleGeneral Science & Technology (science-metrix)Health Disparities (rcdc)HIV InfectionsHepacivirusGermany (mesh)HepatitisSexual and Gender MinoritiesGermanyProspective StudiesChronic32 Biomedical and Clinical Sciences (for-2020)Liver Disease (rcdc)Chronic (mesh)Male (mesh)Humans (mesh)3 Good Health and Well Being (sdg)COVID-19 (mesh)Liver DiseaseIncidenceSexual and Gender Minorities (SGM/LGBT*) (rcdc)QRHomosexualityHealth DisparitiesInfection (hrcs-hc)Infectious Diseases6.1 PharmaceuticalsHIV/AIDSInfectionDigestive Diseases (rcdc)Research ArticleGeneral Science & TechnologyAntiviral Agents (mesh)ScienceClinical SciencesChronic Liver Disease and Cirrhosis610Hepatitis C (mesh)Sexual and Gender Minorities (SGM/LGBT*)Hepatitis - C (rcdc)HIV Infections (mesh)Antiviral AgentsEmerging Infectious Diseases (rcdc)Chronic Liver Disease and Cirrhosis (rcdc)Hepatitis - CIncidence (mesh)HumansProspective Studies (mesh)Homosexuality, MalePandemics3202 Clinical Sciences (for-2020)HIV/AIDS (rcdc)6.1 Pharmaceuticals (hrcs-rac)Biomedical and Clinical SciencesPandemics (mesh)COVID-19Hepatitis C, ChronicEmerging Infectious DiseasesGood Health and Well BeingInfectious Diseases (rcdc)Sexual and Gender Minorities (mesh)Sexually Transmitted InfectionsHepatitis (rcdc)Digestive DiseasesHepacivirus (mesh)Sexually Transmitted Infections (rcdc)

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being